SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria

BACKGROUND: The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. METHODOLOGY/PRINCIPAL FINDINGS: This was a Phase 3, double-blind, randomized, placebo-controlled trial. Partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldblum, Paul J., Adeiga, Adesina, Bakare, Rashidi, Wevill, Silver, Lendvay, Anja, Obadaki, Fatimah, Olayemi, M. Onikepe, Wang, Lily, Nanda, Kavita, Rountree, Wes
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190795/
https://www.ncbi.nlm.nih.gov/pubmed/18213382
http://dx.doi.org/10.1371/journal.pone.0001474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190795/
https://www.ncbi.nlm.nih.gov/pubmed/18213382
http://dx.doi.org/10.1371/journal.pone.0001474

Ejemplares similares